APGE vs AAPL: Which Stock is Better?

Side-by-side comparison of Apogee Therapeutics Inc and Apple Inc in 2026

Comparison Updated:

APGE

Apogee Therapeutics Inc

$74.68

AAPL

Apple Inc

$254.93

Key Metrics Comparison

MetricAPGEAAPLWinner
Market Cap$5.19BN/AAPGE
P/E RatioN/A33.85AAPL
EPS (TTM)$N/A$7.55AAPL
Revenue Growth0.0%6.4%AAPL
Gross Margin0.0%46.9%AAPL

Analyze APGE

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is APGE or AAPL a better investment?

Comparing APGE and AAPL: Apogee Therapeutics Inc has a market cap of $5.19B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between APGE and AAPL?

APGE (Apogee Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: APGE or AAPL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: APGE or AAPL?

AAPL has higher revenue growth at 6.4% vs 0.0% for APGE.

Which company is more profitable: APGE or AAPL?

Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for APGE.

Which is the larger company: APGE or AAPL?

Apogee Therapeutics Inc (APGE) is larger with a market cap of $5.19B compared to N/A for AAPL.

Should I buy APGE or AAPL in 2026?

Both APGE and AAPL have investment merit. APGE trades at $74.68 while AAPL trades at $254.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between APGE and AAPL stock?

Key differences: Market Cap ($5.19B vs N/A), P/E Ratio (N/A vs 33.8x), Revenue Growth (0.0% vs 6.4%), Gross Margin (0.0% vs 46.9%).

Popular Stock Comparisons